FDA approves first-of-its-kind oral therapy for adults with Parkinson’s
The U.S. Food and Drug Administration (FDA) has approved tavapadon — an oral drug aimed at maintaining consistent control of motor symptoms — as a new treatment for adults with Parkinson’s disease.…